Lymphomatoid granulomatosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
*The exact pathogenesis of [disease name] is not completely understood.
*The exact pathogenesis of [disease name] is not completely understood.
OR
OR
*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
*It is understood that Lymphomatoid granulomatosis is the result of infection of T cells by EBV.It is described by the presence of an angiocentric and angiodestructive accumulation of differing numbers of T cells with varying numbers of atypical clonal EBV-positive B cells in a polymorphous inflammatory background.
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
*The progression to [disease name] usually involves the [molecular pathway].
*The pathophysiology of [disease/malignancy] depends on the histological subtype.
 
==Genetics==
==Genetics==
[Disease name] is transmitted in [mode of genetic transmission] pattern.
OR
Genes involved in the pathogenesis of [disease name] include:
*[Gene1]
*[Gene2]
*[Gene3]


OR
The development of [disease name] is the result of multiple genetic mutations such as:
*[Mutation 1]
*[Mutation 2]
*[Mutation 3]


==Associated Conditions==
==Associated Conditions==
Line 47: Line 26:


==Gross Pathology==
==Gross Pathology==
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
On gross pathology,  
 
==Microscopic Pathology==
==Microscopic Pathology==
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
On microscopic histopathological analysis, the presence of an angiocentric and angiodestructive accumulation of differing numbers of T cells with varying numbers of atypical clonal EBV-positive B cells in a polymorphous inflammatory background is seen in Lymphomatoid granulomatosis
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 17:11, 20 November 2018

Lymphomatoid granulomatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphomatoid granulomatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphomatoid granulomatosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphomatoid granulomatosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphomatoid granulomatosis pathophysiology

CDC on Lymphomatoid granulomatosis pathophysiology

Lymphomatoid granulomatosis pathophysiology in the news

Blogs on Lymphomatoid granulomatosis pathophysiology

Directions to Hospitals Treating Lymphomatoid granulomatosis

Risk calculators and risk factors for Lymphomatoid granulomatosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Lymphomatoid granulomatosis arises from T cells, which are Lymphoid cells that are normally involved in Immunity.


Pathophysiology

Physiology

The normal physiology of cell mediated immunity can be understood as follows: Historically, the immune system was divided into two branches: humoral immunity, for which the defending function of immunization could be seen in the humor (cell-free bodily fluid or serum) and cellular immunity, for which the defending function of immunization was associated with cells. CD4 cells or helper T cells provide defense against varying pathogenic organisms. Naive T cells, mature T cells that have yet to come upon an antigen, are transformed into activated effector T cells after coming across an antigen-presenting cells (APCs). These APCs, such as macrophages, dendritic cells, and B cells in some cases, pack antigenic peptides onto the MHC of the cell, in turn introducing the peptide to receptors on T cells. The most important of these APCs are highly specialized dendritic cells; conceivably operating solely to ingest and present antigens.[1]

Pathogenesis=

  • The exact pathogenesis of [disease name] is not completely understood.

OR

  • It is understood that Lymphomatoid granulomatosis is the result of infection of T cells by EBV.It is described by the presence of an angiocentric and angiodestructive accumulation of differing numbers of T cells with varying numbers of atypical clonal EBV-positive B cells in a polymorphous inflammatory background.

Genetics

Associated Conditions

Conditions associated with [disease name] include:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

Gross Pathology

On gross pathology,

Microscopic Pathology

On microscopic histopathological analysis, the presence of an angiocentric and angiodestructive accumulation of differing numbers of T cells with varying numbers of atypical clonal EBV-positive B cells in a polymorphous inflammatory background is seen in Lymphomatoid granulomatosis

References

  1. Denburg JA, Bienenstock J (March 1979). "Physiology of the immune response". Can Fam Physician. 25: 301–7. PMC 2382958. PMID 21297689.

Template:WH Template:WS